An innovative service company focusing on the field of drug quality control

News

Contact Us

You are here:Home >> News >> Company News

Company News

Supply Cimetidine Impurities - SZEB

Time:2023-02-06 Views:270
Cimetidine, sold under the brand name Tagamet among others, is a histamine H2 receptor antagonist that inhibits stomach acid production. It is mainly used in the treatment of heartburn and peptic ulcers.
Cimetidine was developed in 1971 and came into commercial use in 1977. Cimetidine was approved in the United Kingdom in 1976, and was approved in the United States by the Food and Drug Administration for prescriptions in 1979.
To support your analysis and help ensure the accuracy of quality processes, we supply a range of  Cimetidine-related impurities standards with certified COA and characterization data like Mass, HPLC, NMR & TGA report.
The following are some of the impurities of Cimetidine:
  • Previous:Lincomycin Impurity  2024/11/18
  • Next:Bortezomib Impurities - SZEB  2023/01/13